Navigation Links
Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends

NEW YORK, Feb. 10 /PRNewswire/ -- Revenue multiples in the Pharma and Healthcare Information and Technology market experienced a significant half-to-half gain as exhibited by the 81% increase in the median enterprise value/revenue multiple from 1.1 in 1st Half 2009 to 2.0 in 2nd Half 2009. This rise brings the median enterprise value/revenue multiple within 76% of its peak in 1st Half 2008.

(Photo: )

2nd Half 2009 exhibited an increase in both aggregate volume and aggregate value, versus 1st Half 2009. Half-to-half, aggregate value increased 150% from approximately $2 billion to $5 billion, and aggregate volume increased by 15% from 86 deals to 99. The 2nd Half 2009 level of activity, as measured by aggregate value and aggregate volume, is on par with 2nd Half 2007, and slightly below the peak of activity in 1st Half 2008.

For the full year 2009, The Pharma and Healthcare Information and Technology market exhibited negative growth with declines in both aggregate value and aggregate volume of transactions. Total transaction volume declined by 12% from 209 deals in 2008 to 184 in 2009. Aggregate value declined by 16% from $9.43 billion in 2008 to $7.89 billion in 2009.

The largest transaction in the Pharma and Healthcare Information and Technology market in 2009, and going back to 2007, was TPG Capital and CPP Investment Board's proposed acquisition of IMS Health, Inc. for $4.01 billion, announced on November 5th.

Please note that for evaluating aggregate transaction values, value represents total consideration paid by acquirer. For multiples Berkery Noyes uses enterprise values (EV) that normalize values where less than 100% of a company is being acquired or has net debt.

To read the free four page report Click Here (

Berkery Noyes provides skilled transaction management to publicly traded and privately held businesses and private equity groups in both sell-side and buy-side mergers and acquisitions. We have managed transactions ranging from several million to more than four billion dollars in value, with an emphasis on mid market transactions of $10 million to $500 million in enterprise value.

Our clients include private companies seeking a buyer, most of the major international information companies, and private equity firms who use the firm's expertise in locating, analyzing and negotiating with acquisition candidates and in managing divestitures. The firm operates with a staff of thirty professionals serving the information industry.

For more information, visit

SOURCE Berkery Noyes



SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
2. SpectraScience Releases Shareholder Newsletter
3. Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics
4. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
5. ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
8. AdvaMed Releases New Survey Results on DTC Campaigns
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
11. Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program
Post Your Comments:
(Date:10/13/2015)... 13, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... Cell Therapy Catapult to advance development of large ... cell immunotherapy. Under the agreement, the Cell Therapy ... AST-VAC2 to support advanced clinical trials and eventual ... --> The Cell Therapy Catapult is ...
(Date:10/12/2015)... 13, 2015 the United States ... a non-clinical capacity. --> the United States ... a non-clinical capacity. --> The University of Texas MD ... the first high field (1.5 Tesla) MRI-guided linear accelerator in ... system will be operating in a non-clinical capacity. Royal ...
(Date:10/12/2015)... 2015 Given the intricacy of the ... to deliver an ophthalmic drug effectively to a specific ocular ... ocular drug delivery. These include dilution of a drug by ... conjunctiva and drug permeation issues with respect to the cornea, ... eye drops, is lost due to the aforementioned barriers. ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... An increasing number ... Association (FAA) has partnered with the Florida Department of Health and its Bureau ... The FAA Smoke-Free Multifamily Housing Program launched last week at the organization’s 2015 ...
(Date:10/13/2015)... ... 13, 2015 , ... Bambeco, Inc., the premier brand for ... it closed on a $20.5 million funding round led by ABS Capital Partners, ... Company’s continued rapid growth and expansion, broaden the Company’s product offerings, and expand ...
(Date:10/13/2015)... Los Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... game. To incentivize would-be customers, eMarketing Concepts began a $1 promotion – effectively offering ... was a resounding success, and within weeks the company was flooded with phone calls ...
(Date:10/13/2015)... ... October 13, 2015 , ... SPH Analytics today announced the ... organization’s Executive Vice President of Operations, and three Senior Vice Presidents, Robert Davis, ... the company. , Debbie Vereb’s appointment to Executive Vice President of Operations at ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... a new PDF automation tool to batch conversions of CAD drawings, plans, ... 100% document fidelity. , CADConverter eliminates the complexity requirement of specialized applications to ...
Breaking Medicine News(10 mins):